Nexell Sues Sublicensee Miltenyi In Defense Of Stem Cell Purification Patents
This article was originally published in The Gray Sheet
Executive Summary
Nexell Therapeutics' second move to defend patents covering the firm's proprietary stem cell purification technology kicked off with the recent filing of a patent suit in Delaware federal court.